Search Results for: Oramed

Oral insulin reduces liver fat

Israel’s Oramed (see here previously) has reported that its ORMD-0801 oral insulin candidate successfully reduced the liver fat in its Phase 2 trial on Type 2 diabetes patients with non-alcoholic steatohepatitis (“NASH”).  There were no safety issues in the double-blind, … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Phase 3 trial of oral insulin begins

Israel’s Oramed (see here previously) has completed enrollment of patients for the Phase 3 trial of its oral insulin for the treatment of type 2 diabetes. Topline results of the trial are expected early 2023. https://www.prnewswire.com/news-releases/oramed-completes-patient-enrollment-in-pivotal-phase-3-oral-insulin-study-ora-d-013-1-301538222.html

Posted in Israel's Medical Achievements | Leave a comment

Coronavirus news

Less than 6,400 Israelis now have the coronavirus, with just 178 serious cases. Also, an Israeli study shows Vitamin D deficient Covid-19 patients are 14 times more likely to be seriously or critically ill. Finally, Oramed’s oral vaccine has been … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Israel’s oral Covid vaccine

Israel’s Oramed will shortly commence clinical trials of its Oravax vaccine – the world’s first oral Covid-19 vaccine (see here previously). Phase 1/2 trials will take place at Tel Aviv’s Sourasky (Ichilov) Medical Center with Phase 3 in countries desperate … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Developing an oral Covid-19 vaccine

Israel’s Oramed (reported here previously) has launched Oravax – a joint venture with India’s Premas Biotech to develop a Covid-19 vaccine. The vaccine is administered orally (not injected) and targets 3 virus proteins, so should counter any mutations. Human trials … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Trial success for diabetes pill

Israel’s Oramed announced good results of its Phase 2b trials of ORMD-0801 treatment for Type 2 diabetes. Oramed will now discuss its Phase 3 plans with the US FDA. https://www.oramed.com/oramed-reports-positive-results-in-the-final-cohort-of-its-phase-2b-oral-insulin-trial/

Posted in Israel's Medical Achievements | Leave a comment

Oral insulin to replace injections

Israeli TV news about the innovative treatment from Israel’s Oramed that will make life better for many of the 400 million people with diabetes. http://www.israelnationalnews.com/News/News.aspx/214498#.V3uKKjUbNf4

Posted in Israel's Medical Achievements | Leave a comment

Success for diabetes treatment trial

Israeli biotech Oramed has reported success in the Phase IIb study of its insulin capsule.  Oramed highlighted that it was the first time an oral solution showed a significant drop in blood sugar at night.  Oral insulin will replace injected … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Treatment for diabetics in China

Israel’s Oramed has signed a deal worth $50 million that gives China’s Hefei Life Science & Technology (HLST) the rights to Oramed’s oral insulin capsule ORMD-0801 in China, Hong Kong and Macau. ORMD-0801 will help treat the large and growing … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

$50 million to market Israeli oral insulin

China’s Hefei has bought the rights to market the oral insulin capsules developed by Israel’s Oramed on completion of Phase III trials. In a deal worth over $50 million, Hefei gets exclusive rights to market the diabetes treatment in China, … Continue reading

Posted in Economy & Business | Leave a comment